We have interviews with Professor Alan Fenwick, Director of SCI, and Professor David Molyneux, adviser to WHO, who have both been working on NTDs for over 25 years coming up in the next few weeks. A brilliant insight into how the world of NTDs has evolved.
Next week we’ll be live-blogging and tweeting from the Royal College of Physicians for the WHO event: Uniting to combat neglected tropical diseases which will feature Bill Gates; Director-General of WHO Dr. Margaret Chan; Managing Director of the World BankDr. Caroline Anstey, and CEOs of nine leading pharmaceutical companies to name a few!
Just like shopping online for Christmas presents, the real hassle with providing drugs for NTDs is not finding the right supplier or best cost, it’s ensuring they arrive on time and in optimal condition. Pharmaceutical companies may have pledged billions of free vaccines for diseases in developing countries but these drugs cannot travel on good will alone. Continue reading →
The fragmented nature of donations is hindering efforts to implement aid effectively in developing countries
Tanzania receives aid from over 50 countries worldwide in addition to donations from international agencies and institutions. In a country where aid is much needed, Tanzania does all it can to facilitate the money into the economy but the number of financial sources causes problems. Continue reading →